SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029025
Filing Date
2024-12-11
Accepted
2024-12-11 19:53:28
Documents
1
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 form4-12122024_121223.html 4  
1 form4-12122024_121223.xml 4 9828
  Complete submission text file 0001415889-24-029025.txt   11269
Mailing Address OLEMA PHARMACEUTICALS, INC. 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address
Kovacs Shane William Charles (Reporting) CIK: 0001579397 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39712 | Film No.: 241542882

Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)